Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer
NCT03841136
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Extensive-stage Small Cell Lung Cancer
Interventions
DRUG:
anlotinib
Sponsor
Fudan University